OSE Pharma (France) Buy Hold or Sell Recommendation
OSE Stock | EUR 5.38 0.38 7.60% |
Assuming the 90 days trading horizon and your highly speculative risk level, our recommendation regarding OSE Pharma SA is 'Buy'. Macroaxis provides OSE Pharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding OSE positions. The advice algorithm takes into account all of OSE Pharma's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting OSE Pharma's buy or sell advice are summarized below:
Real Value 4.63 | Hype Value 5 | Market Value 5.38 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell OSE Pharma SA given historical horizon and risk tolerance towards OSE Pharma. When Macroaxis issues a 'buy' or 'sell' recommendation for OSE Pharma SA, the advice is generated through an automated system that utilizes algorithms and statistical models.
OSE |
Execute OSE Pharma Buy or Sell Advice
The OSE recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on OSE Pharma SA. Macroaxis does not own or have any residual interests in OSE Pharma SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute OSE Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Buy
Market Performance | OK | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
OSE Pharma Trading Alerts and Improvement Suggestions
OSE Pharma SA is way too risky over 90 days horizon | |
OSE Pharma SA appears to be risky and price may revert if volatility continues | |
The company reported the revenue of 26.31 M. Net Loss for the year was (16.85 M) with profit before overhead, payroll, taxes, and interest of 26.31 M. | |
OSE Pharma SA has accumulated about 33.58 M in cash with (9.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.84. | |
Roughly 39.0% of the company outstanding shares are owned by corporate insiders |
OSE Pharma Returns Distribution Density
The distribution of OSE Pharma's historical returns is an attempt to chart the uncertainty of OSE Pharma's future price movements. The chart of the probability distribution of OSE Pharma daily returns describes the distribution of returns around its average expected value. We use OSE Pharma SA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of OSE Pharma returns is essential to provide solid investment advice for OSE Pharma.
Mean Return | 0.63 | Value At Risk | -4.17 | Potential Upside | 5.23 | Standard Deviation | 6.95 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of OSE Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
OSE Pharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to OSE Pharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that OSE Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a OSE stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.61 | |
β | Beta against NYSE Composite | 0.29 | |
σ | Overall volatility | 7.13 | |
Ir | Information ratio | 0.08 |
OSE Pharma Volatility Alert
OSE Pharma SA is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure OSE Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact OSE Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.OSE Pharma Fundamentals Vs Peers
Comparing OSE Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze OSE Pharma's direct or indirect competition across all of the common fundamentals between OSE Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as OSE Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of OSE Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing OSE Pharma by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare OSE Pharma to competition |
Fundamentals | OSE Pharma | Peer Average |
Return On Equity | -0.15 | -0.31 |
Return On Asset | -0.0528 | -0.14 |
Profit Margin | (0.22) % | (1.27) % |
Operating Margin | (0.25) % | (5.51) % |
Current Valuation | 128.18 M | 16.62 B |
Shares Outstanding | 18.44 M | 571.82 M |
Shares Owned By Insiders | 39.03 % | 10.09 % |
Shares Owned By Institutions | 1.81 % | 39.21 % |
Price To Earning | 10.60 X | 28.72 X |
Price To Book | 2.64 X | 9.51 X |
Price To Sales | 3.69 X | 11.42 X |
Revenue | 26.31 M | 9.43 B |
Gross Profit | 26.31 M | 27.38 B |
EBITDA | (13.72 M) | 3.9 B |
Net Income | (16.85 M) | 570.98 M |
Cash And Equivalents | 33.58 M | 2.7 B |
Cash Per Share | 0.84 X | 5.01 X |
Total Debt | 34.77 M | 5.32 B |
Debt To Equity | 7.20 % | 48.70 % |
Current Ratio | 2.54 X | 2.16 X |
Book Value Per Share | 2.53 X | 1.93 K |
Cash Flow From Operations | (9.92 M) | 971.22 M |
Earnings Per Share | (0.41) X | 3.12 X |
Target Price | 14.1 | |
Number Of Employees | 60 | 18.84 K |
Beta | 1.06 | -0.15 |
Market Capitalization | 104.49 M | 19.03 B |
Total Asset | 101.88 M | 29.47 B |
Retained Earnings | 25 M | 9.33 B |
Working Capital | 22 M | 1.48 B |
Current Asset | 30 M | 9.34 B |
Current Liabilities | 8 M | 7.9 B |
Z Score | 1.8 | 8.72 |
OSE Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as OSE . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 32307.15 | |||
Daily Balance Of Power | 0.7037 | |||
Rate Of Daily Change | 1.08 | |||
Day Median Price | 5.22 | |||
Day Typical Price | 5.27 | |||
Price Action Indicator | 0.35 | |||
Period Momentum Indicator | 0.38 |
About OSE Pharma Buy or Sell Advice
When is the right time to buy or sell OSE Pharma SA? Buying financial instruments such as OSE Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having OSE Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Alcohol Thematic Idea Now
Alcohol
Companies involved in production and distribution of wines and alcoholic beverages. The Alcohol theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alcohol Theme or any other thematic opportunities.
View All Next | Launch |
Check out OSE Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the OSE Pharma SA information on this page should be used as a complementary analysis to other OSE Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for OSE Stock analysis
When running OSE Pharma's price analysis, check to measure OSE Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OSE Pharma is operating at the current time. Most of OSE Pharma's value examination focuses on studying past and present price action to predict the probability of OSE Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OSE Pharma's price. Additionally, you may evaluate how the addition of OSE Pharma to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |